Form D · Pharmaceuticals
Relief Therapeutics Holding SA
Ch 1202 Geneva, V8 · CIK 0001854078
Offering snapshot reported Aug 25, 2021 · SEC filing
- Reported sold
- $16.4M Offering amount: $16.4M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 25, 2021 | Initial | $16,404,000 | No comparison | Not reported | SEC filing |
| Mar 30, 2021 | Initial | $10,745,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-411279
Source: Form D, filed Aug 25, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gilles Della Corte | Executive |
| Paolo Galfetti | Director |
| Patrice Jean | Director |
| Taneli Jouhikainen | Executive |
| Tom Plitz | Director |
| Raghuram Selvaraju | Director |
| Chris Stijnen | Executive |
| Chris Stinjen | Executive |
| Jack Weinstein | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Avenue De Secheron 15
Ch 1202 Geneva, V8, NA
Ch 1202 Geneva, V8, NA